Publications by authors named "T Fukumori"
Article Synopsis
- Immunocompromised patients with hematologic malignancies, particularly those on anti-CD20 treatments like rituximab, face a higher risk of prolonged SARS-CoV-2 infection, and antiviral therapy may improve outcomes.
- A case study details a 68-year-old man who developed acute acalculous cholecystitis after extended treatment with a specific antiviral combination (nirmatrelvir/ritonavir) for persistent COVID-19 following lymphoma treatment.
- The study suggests that ongoing antiviral therapy, along with COVID-19, might lead to complications like elevated liver enzymes and cholecystitis, highlighting the need for careful monitoring during treatment.
Background/aim: Intermediate-risk prostate cancer (PCa) is a highly heterogeneous disease. Although low-dose-rate brachytherapy (LDR-BT) is mainly used for low- to intermediate-risk PCa, limited reports have evaluated the detailed differences in outcomes, including differences between patients with ISUP grade group (GG) 2 and GG3 intermediate-risk PCa. This study aimed to investigate the differences in outcomes between intermediate-risk Japanese patients with GG2 and GG3 PCa who underwent LDR-BT.
View Article and Find Full Text PDFBackground: Nurses providing end-of-life care experience not only burnout and compassion fatigue, but also positive effects such as compassion satisfaction. Nurses' compassion satisfaction was shown to be related to job satisfaction, work engagement, and nurse caring. Studies in emergency departments, intensive care units, oncology wards, and general wards have identified work environmental factors associated with nurses' compassion satisfaction, but no similar studies have been conducted in palliative care units or home care settings.
View Article and Find Full Text PDFThis study aimed to examine the reliability and validity of the Japanese version of the Chronic Pain Acceptance Questionnaire (CPAQ-8J). A total of 108 outpatients with chronic pain completed the CPAQ-8 questionnaire, along with the Acceptance and Action Questionnaire-II, Hospital Anxiety and Depression Scale, Pain Disability Assessment Scale, Numerical Rating Scale, and EuroQol 5 dimensions 5-level. Confirmatory factor analyses examined the factor structure.
View Article and Find Full Text PDFArticle Synopsis
- A nationwide surveillance study in Japan assessed the antimicrobial susceptibility of bacterial pathogens related to respiratory tract infections, collecting data from June 2019 to December 2020.
- The study analyzed 932 bacterial strains from 32 medical facilities, finding notable resistance rates, such as 35.3% for methicillin-resistant Staphylococcus aureus and 16.2% for β-lactamase-producing resistant Haemophilus influenzae.
- Results from this surveillance aim to inform treatment strategies for respiratory infections in Japan and promote the responsible use of antimicrobial drugs.